ConductScience.org, home

Cell line · CVCL_0439

MNNG/HOS Cl #5

Cancer cell line, Homo sapiens. Osteosarcoma. 32 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. MNNG/HOS Cl #5. Cell lines, record CVCL_0439. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0439

On this page

Cell line

As Cellosaurus gives it.

Name
MNNG/HOS Cl #5
Accession
CVCL_0439
RRID
RRID:CVCL_0439
Synonyms
MNNG/HOS, MNNG-HOS, MNNG HOS, HOS-MNNG, HOS/MNNG, MNNGHOS, MNNG-HOS (Cl#5), MNNG/HOS Clone F-5, MNNG, R-1059-D, TE85, Te85, TE-85, HOS-TE85, Hos TE-85, HOS TE 85, HOS TE85, HOS (TE85), HOS(TE85), HOS (TE85, Clone F5), MNNG-HOS (TE 85, clone F-5), TE-85 clone F-5, HOS-Te85, TE 85.T, TE 85 ClF-5, HOS-TE85 clone 5, TE-85 clone 5
Species
Homo sapiens (Human)
Sex
Female
Age at sampling
13Y
Category
Cancer cell line
Diseases
Osteosarcoma (NCIt C9145); Osteosarcoma (ORDO Orphanet_668)
Derived from
Bone, right femur (in situ)
Parent
HOS (CVCL_0312)
Secondary accessions
CVCL_3952
Entry created
2012-04-04
Entry updated
2025-11-27

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers32

2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

PaperJournalYearHow we knowRetractedSource
An inertial-based spiral device for separating rare tumor cells from liquid biopsies.Bioeng Transl Med2026Its Methods give the RRID and name the linePubMed
Prognostic characteristics of disulfidptosis-related genes across cancers and their potential implications in osteosarcoma.Sci Prog2026Its Methods give the RRID and name the linePubMed
TENT5A Maintains MYC mRNA Stability to Enhance Osteosarcoma Stemness.Cancer Res2026Its Methods give the RRID and name the linePubMed
Tumor Extracellular Vesicles lncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m6A-Dependent hnRNPA2B1/COX-2 Axis.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
MAT2A enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma.Commun Biol2026Its Methods give the RRID and name the linePubMed
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma.Cancer Res Commun2025Its Methods give the RRID and name the linePubMed
Methionine intervention induces PD-L1 expression to enhance the immune checkpoint therapy response in MTAP-deleted osteosarcoma.Cell Rep Med2025Its Methods give the RRID and name the linePubMed
Vascular Niche Facilitates Acquired Drug Resistance to c-Met Inhibitor in Originally Sensitive Osteosarcoma Cells.Cancers (Basel)2022Its Methods give the RRID and name the linePubMed
Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells.Front Oncol2022Its Methods give the RRID and name the linePubMed
METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.EBioMedicine2022Its Methods give the RRID and name the linePubMed

1 to 10 of 32

See all 32 papers

Relatives12

RelationCell lineAccessionProblemSource
ParentHOSCVCL_0312Cell lines
Derived from itC1ICVCL_2402Cell lines
Derived from itE111CVCL_2441Cell lines
Derived from itFNR-85-Cl 1CVCL_ZZ44Cell lines
Derived from itFNR-85-Cl 2CVCL_ZZ45Cell lines
Derived from itFNR-85-Cl 3CVCL_ZZ46Cell lines
Derived from itFNR-85-Cl 5CVCL_ZZ47Cell lines
Derived from itII bCVCL_4347Cell lines
Derived from itKHOS/NPCVCL_2546Cell lines
Derived from itKRIBCVCL_AU05Cell lines

Cell banks7

Cell bankCatalog numberStatusSource
ATCCCRL-1547ATCC
ATCCCRL-7734DiscontinuedCellosaurus
ATCCCRL-7735DiscontinuedCellosaurus
CLS300289CLS
ECACC87070201ECACC
KCBKCB 2016037YJCellosaurus
KCLB21543KCLB

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0439

GET https://conductscience.org/api/cell-lines/v1/CVCL_0439/papers?page=2